Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UPDATE: FDA Approves Vaccines for 2010-11 Flu Season

Fri, 30th Jul 2010 19:57

(Update in last paragraph with list of companies making the flu vaccine.) By Shayndi Raice Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--The U.S. Food and Drug Administration announced Friday it has approved vaccines for the 2010-2011 flu season. The latest flu vaccine will prevent against three strains of influenza, including the H1N1 virus, or swine flu, that caused last year's pandemic. Karen Midthun, acting director of the FDA's center for biologics evaluation and research, said the best way to protect against the flu is to get vaccinated annually. "The availability of a new seasonal influenza vaccine each year is an important tool in the prevention of influenza related illnesses and death," she added. Because H1N1 developed after the flu vaccine was produced, a separate vaccine to address swine flu was needed. The FDA's approval means that only one vaccine will be required for all strains of influenza. Companies that will be producing a version of the vaccine include CSL Limited (CSL), Novartis Vaccines and Diagnostics (NOVN), GlaxoSmithKline Biologicals (GSK), ID Biomedical Corporation, MedImmune Vaccines Inc., and Sanofi Pasteur Inc. (SNY). -By Shayndi Raice, Dow Jones Newswires; 202-862-9291; shayndi.raice@dowjones.com (END) Dow Jones Newswires July 30, 2010 14:57 ET (18:57 GMT)

Related Shares

More News
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed *

3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8% *

3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective ...

3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.